Senseonics Holdings, Inc. (AMEX:SENS) has scheduled a conference call for 9th November 2020 at 4:30 PM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.senseonics.com
Earnings Expectation
Senseonics Holdings, Inc. is expected to report third quarter earnings results, after market close, on Monday 9th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.06 per share from revenue of $ 0.54 million. Looking ahead, the full year loss are expected at $ 0.36 per share on the revenues of $ 1.74 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 15.00 million ~ $ 20.00 million
Click Here For More Historical Outlooks Of Senseonics Holdings, Inc.
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a collaboration agreement Roche Diabetes Care, Inc.
